Literature DB >> 33998949

Effect of vaccine effectiveness and safety on COVID-19 vaccine acceptance in Detroit, Michigan, July 2020.

Abram L Wagner1, Sherri Sheinfeld Gorin2, Matthew L Boulton1,3, Brian A Glover1, Jeffrey D Morenoff4.   

Abstract

This study examined whether future COVID-19 vaccine acceptance differed based on an experimental manipulation of the vaccine safety and effectiveness profile. Data come from the Detroit Metro Area Community Study, a population-based study conducted July 15-20, 2020. Participants were asked whether they would get a new COVID-19 vaccine after being randomly assigned information about the vaccine's effectiveness (50% or 95%) and chance of fever (5% or 20%). Among 1,117 Detroiters, 51.3% would accept a COVID-19 vaccine that is 50% effective and 77.1% would accept a vaccine that is 95% effective. Women and adults ≥65 were more accepting of a vaccine; Black Detroiters were less accepting. Believing vaccines to be important, effective, and safe was associated with higher acceptance. Uptake of a COVID-19 may be limited, depending on perceived vaccine effectiveness and general attitudes toward vaccines. Public health approaches to modifying these attitudes will be especially important in the Black community.

Entities:  

Keywords:  COVID-19 vaccine; Michigan; adult; pandemics; race/ethnicity

Mesh:

Substances:

Year:  2021        PMID: 33998949      PMCID: PMC8381818          DOI: 10.1080/21645515.2021.1917233

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  17 in total

1.  Easy SAS calculations for risk or prevalence ratios and differences.

Authors:  Donna Spiegelman; Ellen Hertzmark
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

Review 2.  Field effectiveness of live attenuated measles-containing vaccines: a review of published literature.

Authors:  Amra Uzicanin; Laura Zimmerman
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

Review 3.  SARS-CoV-2 Vaccines.

Authors:  C Buddy Creech; Shannon C Walker; Robert J Samuels
Journal:  JAMA       Date:  2021-04-06       Impact factor: 56.272

4.  The Johnson & Johnson Vaccine for COVID-19.

Authors:  Edward H Livingston; Preeti N Malani; C Buddy Creech
Journal:  JAMA       Date:  2021-04-20       Impact factor: 56.272

5.  Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.

Authors:  Shibo Jiang
Journal:  Nature       Date:  2020-03       Impact factor: 49.962

6.  Addressing Influenza Vaccination Disparities During the COVID-19 Pandemic.

Authors:  Lisa A Grohskopf; Leandris C Liburd; Robert R Redfield
Journal:  JAMA       Date:  2020-09-15       Impact factor: 56.272

7.  Preferences for vaccination program attributes among parents of young infants in Shanghai, China.

Authors:  Zhuoying Huang; Abram L Wagner; Muzi Lin; Xiaodong Sun; Brian J Zikmund-Fisher; Matthew L Boulton; Jia Ren; Lisa A Prosser
Journal:  Hum Vaccin Immunother       Date:  2020-01-24       Impact factor: 3.452

8.  Discussion of Average versus Extreme Case Severity in Pandemic Risk Communications.

Authors:  Brian J Zikmund-Fisher; Aaron M Scherer; Megan Knaus; Enny Das; Angela Fagerlin
Journal:  Emerg Infect Dis       Date:  2017-04       Impact factor: 6.883

9.  Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective.

Authors:  Carl A Latkin; Lauren Dayton; Grace Yi; Arianna Konstantopoulos; Basmattee Boodram
Journal:  Soc Sci Med       Date:  2021-01-08       Impact factor: 4.634

10.  A global survey of potential acceptance of a COVID-19 vaccine.

Authors:  Jeffrey V Lazarus; Scott C Ratzan; Adam Palayew; Lawrence O Gostin; Heidi J Larson; Kenneth Rabin; Spencer Kimball; Ayman El-Mohandes
Journal:  Nat Med       Date:  2020-10-20       Impact factor: 53.440

View more
  12 in total

Review 1.  Interventions to increase COVID-19 vaccine uptake: a scoping review.

Authors:  Marike Andreas; Claire Iannizzi; Emma Bohndorf; Ina Monsef; Vanessa Piechotta; Joerg J Meerpohl; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2022-08-03

2.  Immunogenicity and Reactogenicity of the Booster Dose of COVID-19 Vaccines and Related Factors: A Panel Study from the General Population in Serbia.

Authors:  Maja Stosic; Marija Milic; Milos Markovic; Ivana Kelic; Zoran Bukumiric; Marko Veljkovic; Darija Kisic Tepavcevic; Vladan Saponjic; Dragana Plavsa; Sofija Jovanovic; Verica Jovanovic
Journal:  Vaccines (Basel)       Date:  2022-05-25

3.  COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity.

Authors:  Janina I Steinert; Henrike Sternberg; Hannah Prince; Barbara Fasolo; Matteo M Galizzi; Tim Büthe; Giuseppe A Veltri
Journal:  Sci Adv       Date:  2022-04-27       Impact factor: 14.957

4.  COVID-19 vaccine perceptions in the initial phases of US vaccine roll-out: an observational study on reddit.

Authors:  Navin Kumar; Isabel Corpus; Meher Hans; Nikhil Harle; Nan Yang; Curtis McDonald; Shinpei Nakamura Sakai; Kamila Janmohamed; Keyu Chen; Frederick L Altice; Weiming Tang; Jason L Schwartz; S Mo Jones-Jang; Koustuv Saha; Shahan Ali Memon; Chris T Bauch; Munmun De Choudhury; Orestis Papakyriakopoulos; Joseph D Tucker; Abhay Goyal; Aman Tyagi; Kaveh Khoshnood; Saad Omer
Journal:  BMC Public Health       Date:  2022-03-07       Impact factor: 3.295

5.  Encouraging COVID-19 vaccination via an evolutionary theoretical approach: A randomized controlled study in Japan.

Authors:  Tsuyoshi Okuhara; Hiroko Okada; Eiko Goto; Aiko Tsunezumi; Yumi Kagawa; Takahiro Kiuchi
Journal:  Patient Educ Couns       Date:  2022-02-18

6.  Changes in COVID-19 risk perceptions: methods of an internet survey conducted in six countries.

Authors:  Felicia Zhang; Shu-Fang Shih; Harapan Harapan; Yogambigai Rajamoorthy; Hao-Yuan Chang; Awnish Singh; Yihan Lu; Abram L Wagner
Journal:  BMC Res Notes       Date:  2021-11-25

7.  Vaccinations, Mobility and COVID-19 Transmission.

Authors:  Jianfeng Guo; Chao Deng; Fu Gu
Journal:  Int J Environ Res Public Health       Date:  2021-12-23       Impact factor: 3.390

8.  Types of anticipated affect that encourage and discourage vaccination: a scoping review protocol.

Authors:  Tsuyoshi Okuhara; Hiroko Okada; Eiko Goto; Aiko Tsunezumi; Yumi Kagawa; Takahiro Kiuchi
Journal:  BMJ Open       Date:  2022-04-15       Impact factor: 3.006

Review 9.  Ending the Pandemic: How Behavioural Science Can Help Optimize Global COVID-19 Vaccine Uptake.

Authors:  Michael Vallis; Simon Bacon; Kim Corace; Keven Joyal-Desmarais; Sherri Sheinfeld Gorin; Stefania Paduano; Justin Presseau; Joshua Rash; Abebaw Mengistu Yohannes; Kim Lavoie
Journal:  Vaccines (Basel)       Date:  2021-12-22

10.  Mediators of Racial Differences in COVID-19 Vaccine Acceptance and Uptake: A Cohort Study in Detroit, MI.

Authors:  Abram L Wagner; Lydia Wileden; Trina R Shanks; Susan Door Goold; Jeffrey D Morenoff; Sherri N Sheinfeld Gorin
Journal:  Vaccines (Basel)       Date:  2021-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.